Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHTCF.L Regulatory News (HTCF)

  • There is currently no data for HTCF

FACTSHEET - NOVEMBER 2015

17 Dec 2015 07:00

RNS Number : 3340J
BlueCrest AllBlue Fund Ltd
17 December 2015
 



FOR IMMEDIATE RELEASE

 

17 December 2015

 

BLUECREST ALLBLUE FUND LIMITED

FACTSHEET - NOVEMBER 2015

 

"Return of capital by AllBlue"

 

On 1st December BlueCrest Capital Management LP, as investment manager of AllBlue and the underlying funds, along with the directors of AllBlue, notified the Company of their intention to return capital to investors with effect from the 4th January 2016 dealing date. This includes the return of the capital of BlueCrest AllBlue Fund Limited (BCAB) invested in AllBlue and the leveraged version of AllBlue. Thereafter, BlueCrest will become a private investment partnership. The full announcement can be found at www.bluecrestallblue.com.

 

Based on the information provided to the board by BlueCrest, approximately 70% of the redemption proceeds will be received by the Company by the end of January 2016, 85% by the end of April 2016 and the balance as soon as practicable thereafter.

 

The board has announced that it will offer all shareholders the opportunity to elect to receive cash proceeds but it has also received feedback from a number of shareholders of their desire to remain invested. Concurrently, the board has been approached by a considerable number of investment institutions with proposals for the Company to appoint a new investment manager, invest in other funds or to offer a rollover opportunity into other investment vehicles.

 

The board is currently evaluating these proposals and conducting an initial round of manager interviews before Christmas after which it will assess the viability of these proposals with a view to making a recommendation to shareholders. The board anticipates that any recommendation would be forthcoming before the end of January.

 

In the meantime, the Company has ceased all purchases of shares in the market and conversions between classes. It has also changed the basis of the estimated and final net asset value calculations with effect from 1st December 2015. Henceforth, these calculations will include a discount factor on the anticipated cash flows and also a provision for estimated costs associated with any return of capital and liquidation. Any costs associated with a rollover or appointment of an investment manager will not be borne by shareholders who elect to receive cash.

 

Although a continuation vote has been triggered by the Sterling Class of BCAB, given the options outlined above the board will not be offering a continuation vote to shareholders in the near term.

 

The board will keep shareholders up to date with relevant developments as they arise and all shareholders are recommended to review the Company's Regulatory Information Service announcements.

 

"November saw another positive performance"

 

BCAB produced another positive performance of 0.7% in November, bringing the gain for the year to date to 3.9% (Sterling Class NAV). The rolling 12 month return fell slightly to 4.0% delivered with a stable volatility of 3.0%.

 

Market movements were more muted in November as investors awaited indications of central bank policy and clarity from economic data.

 

Against this backdrop 6 of the 7 strategies produced positive performance with the strongest gains coming from BlueCrest Emerging Markets, BlueCrest Equity Strategies and BlueTrend 2x. Only BlueCrest Quantitative Equity saw negative performance. Allocations remained unchanged for December and the funds are undertaking an orderly and managed liquidation of positions.

 

 

Disclaimer:

This document is directed only at: (i) persons having professional experience in matters relating to investments who fall within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005; or (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and persons who receive this document who do not fall within (i) or (ii) above should not rely on or act upon this document.

 

This document is issued by BlueCrest AllBlue Fund Limited (the "Company") to and for the information of its existing shareholders and does not in any jurisdiction constitute investment advice or an invitation to invest in the shares or any other securities of the Company or any other entity (body corporate or otherwise).

 

The Company has used reasonable care to ensure that the information included in this document is accurate at the date of its issue, but does not undertake to update or revise the information, including any information relating to AllBlue Limited and its underlying funds (the "Funds") provided by BlueCrest Capital Management (UK) LLP or any member of the BlueCrest group of companies (as applicable) ("BlueCrest"), or guarantee the accuracy of such information. To the extent permitted by law neither the Company, the Funds, BlueCrest nor their directors or officers shall be liable for any loss or damage that anyone may suffer in reliance on such information.

 

The information in this document may be changed by the Company at any time. Past performance cannot be relied on as a guide to future performance. The Company's investment strategy is speculative and entails substantial risks. The value of an investment may go down as well as up and some or all of the total amount invested may be lost. This document may not, in whole or in part, directly or indirectly, be taken, transmitted or distributed into the United States of America, its territories or possessions or made available to any national, resident or citizen of the United States of America or any other jurisdiction where applicable laws prohibit its release, distribution or publication. Any failure to comply with these restrictions may be a violation of the law in relevant jurisdictions.

 

JTC (Guernsey) Limited

Secretary

 

Tel: Guernsey 01481 702400

 

END OF ANNOUNCEMENT

E&OE - in transmission

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLLFVDFVLRLIE
Date   Source Headline
1st Nov 20232:02 pmRNSCompany Update
27th Oct 20235:30 pmRNSHighbridge Tactical Credit Fund
18th Oct 20231:37 pmRNSCompany Update
3rd Oct 20239:36 amRNSDirector Declaration
28th Apr 20232:33 pmRNSTotal Voting Rights
17th Apr 20237:00 amRNSShares in issue
30th Mar 20235:02 pmRNSHalf-year Report
29th Mar 20232:11 pmRNSReturn of Capital
29th Mar 20232:08 pmRNSCash Distribution
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20237:00 amRNSDirector Declaration
16th Mar 20237:00 amRNSCompany Update and Return of Capital Information
15th Mar 20234:36 pmRNS2019 Redemption Portfolio
15th Mar 20234:30 pmRNSNet Asset Value(s)
7th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSChange of Registered Office
2nd Dec 202211:44 amRNSResult of AGM
21st Nov 20223:05 pmRNSHolding(s) in Company
9th Nov 20227:00 amRNSNotice of AGM
8th Nov 20224:00 pmRNSNet Asset Value(s)
8th Nov 20224:00 pmRNS2019 Redemption Portfolio
7th Nov 20225:00 pmRNS2019 Redemption Portfolio
7th Nov 20224:58 pmRNSNet Asset Value(s)
2nd Nov 20227:00 amRNSDistribution
31st Oct 20223:22 pmRNSAnnual Financial Report
20th Oct 202210:47 amRNSAudit Opinion
18th Oct 202211:04 amRNSNet Asset Value(s)
18th Oct 202211:03 amRNS2019 Redemption Portfolio
25th Aug 20224:50 pmRNSNet Asset Value(s)
25th Aug 20224:41 pmRNS2019 Redemption Portfolio
1st Aug 20229:51 amRNS2019 Redemption Portfolio
1st Aug 20229:45 amRNSNet Asset Value(s)
5th Jul 202211:09 amRNS2019 Redemption Portfolio
5th Jul 202211:03 amRNSNet Asset Value(s)
1st Jun 202211:22 amRNSNet Asset Value(s)
1st Jun 202211:20 amRNS2019 Redemption Portfolio
7th Apr 20228:38 amRNSNet Asset Value(s)
7th Apr 20228:24 amRNS2019 Redemption Portfolio
25th Mar 202211:22 amRNSNet Asset Value(s)
25th Mar 202211:15 amRNS2019 Redemption Portfolio
22nd Mar 202211:00 amRNSCash Exit Payment
21st Mar 20223:02 pmRNSInterim Report and Accounts
2nd Mar 202210:23 amRNS2019 Redemption Portfolio
2nd Mar 202210:20 amRNSNet Asset Value(s)
23rd Feb 20224:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
21st Feb 202211:21 amRNSHolding(s) in Company
20th Jan 20225:22 pmRNSHolding(s) in Company
6th Jan 20225:06 pmRNS2019 Redemption Portfolio
6th Jan 20224:59 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.